Clinical Trial Update: Intraperitoneal Ropivacaine Nebulization for Pain Control After Laparoscopic Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating intraperitoneal ropivacaine delivered via nebulization for pain control after laparoscopic cholecystectomy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gallbladder Disease

Drugs mentioned

• Ropivacaine (Ropivacaine)

Snippet

Sponsor: San Gerardo Hospital | Conditions: Laparoscopic Cholecystectomy | Phase 3 | Status: COMPLETED